Company Filing History:
Years Active: 2007
Title: Lal Cheema: Innovator in Cardiac Treatments
Introduction
Lal Cheema is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-arrhythmic compounds. With a total of 2 patents, his work is recognized for its potential impact on cardiac health.
Latest Patents
Cheema's latest patents include innovative formulations such as 3,7-Diazabicyclo [3.3.1] compounds that serve as anti-arrhythmic agents. These formulations provide substantially crystalline forms of various compounds, which are useful in treating cardiac arrhythmias. Additionally, he has developed a process for the preparation of oxabispidines, which involves a series of chemical reactions leading to the creation of valuable pharmaceutical intermediates.
Career Highlights
Lal Cheema is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on groundbreaking research and development in the field of cardiac treatments. His contributions have been instrumental in advancing the understanding and treatment of heart-related conditions.
Collaborations
Throughout his career, Cheema has collaborated with esteemed colleagues such as David Cladingboel and Rhona Sinclair. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Lal Cheema's work in the pharmaceutical industry exemplifies the importance of innovation in developing effective treatments for cardiac conditions. His patents and collaborations highlight his commitment to improving patient outcomes through scientific advancement.